# Quality Score Report: TASK-006 Comparative Effectiveness Analysis (Iteration 5)

> adv-scorer | S-014 LLM-as-Judge | PROJ-014 | 2026-02-28
> Target: `phase-2/comparative-effectiveness.md` (Revision 5 / Iteration 5)
> Prior scores: I1 = 0.743 (REJECTED), I2 = 0.790 (REJECTED), I3 = 0.893 (REVISE), I4 = 0.930 (REVISE)
> C4 threshold: >= 0.95

---

## Document Sections

| Section | Purpose |
|---------|---------|
| [L0 Executive Summary](#l0-executive-summary) | Score, verdict, top action item |
| [Scoring Context](#scoring-context) | Deliverable metadata, strategy, SSOT reference |
| [Score Summary](#score-summary) | Composite score, threshold, verdict |
| [Dimension Scores](#dimension-scores) | Weighted table with evidence summary |
| [Detailed Dimension Analysis](#detailed-dimension-analysis) | Per-dimension evidence, gaps, improvement path |
| [I4 Constraint Resolution Verification](#i4-constraint-resolution-verification) | Confirmation that the A-23 external constraint is resolved and split confidence is consistent |
| [Remaining Findings](#remaining-findings) | Unresolved issues after I5 |
| [Improvement Recommendations](#improvement-recommendations) | Priority-ordered remediation |
| [Leniency Bias Check](#leniency-bias-check) | Anti-leniency self-verification |
| [Session Context Handoff](#session-context-handoff) | Orchestrator handoff schema |

---

## L0 Executive Summary

**Score:** 0.933/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Completeness (0.92)

**One-line assessment:** I5 successfully confirms A-23 as T1-verified with consistent split-confidence handling (MEDIUM for negation accuracy, LOW for 60% claim) throughout the document, raising Evidence Quality from 0.91 to 0.93 and Traceability from 0.93 to 0.94, but the composite of 0.933 remains below the 0.95 C4 threshold — the remaining gap is driven by Completeness (0.92) and the two dimensions still constrained by inherent evidence access limitations (I-28/I-32 URL unavailability).

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/phase-2/comparative-effectiveness.md`
- **Deliverable Type:** Research Analysis
- **Criticality Level:** C4
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Prior Adversary Findings Incorporated:** Yes — I4 report at `phase-2/adversary-comparative-effectiveness-i4.md` (0 document-quality findings; 1 external evidence constraint: A-23 T1-unverified)
- **Scored:** 2026-02-28

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.933 |
| **Threshold** | 0.95 (C4, H-13) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | Yes — I4 report (0 document-quality findings; A-23 external constraint now resolved) |
| **I4 External Constraint Resolved** | 1 of 1 (A-23 confirmed T1-verified) |
| **I4 Document-Quality Findings** | 0 (none to resolve) |
| **New Findings in I5** | 0 |
| **Remaining Findings** | 0 document-quality findings; 1 external evidence constraint |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.92 | 0.184 | A-23 upgrade complete at all document locations; CV-002-I2 indirect path (I-28/I-32) unchanged; completeness ceiling unchanged from I4 |
| Internal Consistency | 0.20 | 0.95 | 0.190 | Split confidence (MEDIUM negation accuracy, LOW 60% claim) applied consistently at all 12+ locations; no contradictions found; I5 changes do not introduce new inconsistencies |
| Methodological Rigor | 0.20 | 0.93 | 0.186 | Construct-scope constraint (negation comprehension ≠ hallucination rate) applied rigorously; partial upgrade is methodologically justified and not inflated; structural circularity limitation unchanged |
| Evidence Quality | 0.15 | 0.93 | 0.1395 | A-23 confirmed T1 (EMNLP 2025 Findings, https://aclanthology.org/2025.findings-emnlp.761); D2 now has confirmed T1 evidence for negation accuracy; I-28/I-32 indirect path persists |
| Actionability | 0.15 | 0.93 | 0.1395 | No changes in I5 to PG-001 through PG-005; all five items unconditional; PG-003 null-result default fully specified (from I4); Phase 2 Inconclusive Scenario guidance complete |
| Traceability | 0.10 | 0.94 | 0.094 | A-23 ACL Anthology URL (https://aclanthology.org/2025.findings-emnlp.761) added at all active content locations; PS Integration confidence derivation updated to 0.68 with verifiable formula; I-28/I-32 indirect path persists |
| **TOTAL** | **1.00** | | **0.933** | |

**Note on leniency bias counteraction:** Initial per-dimension raw scores were Completeness 0.93, Evidence Quality 0.94, Traceability 0.94. Per leniency bias counteraction, uncertain scores at adjacent-band boundaries are resolved downward. Completeness is resolved to 0.92: the A-23 upgrade is well-executed but does not extend completeness beyond what I4 already achieved with full T1-unverified disclosure — the CV-002-I2 indirect path limitation is unchanged. Evidence Quality is resolved to 0.93: I4 scorer's predicted range was "approximately 0.93-0.94"; resolve to the lower bound given I-28/I-32 URL access constraint persists. Traceability is held at 0.94: A-23's ACL Anthology URL is a direct and verifiable primary source addition (not indirect) and this is specific, documentable evidence for the 0.94 score; the I-28/I-32 indirect path limits this from 0.95+. Internal Consistency is held at 0.95 — the split-confidence handling is verified consistent at all active content locations and no contradictions are found. Methodological Rigor is held at 0.93 — the construct-scope constraint is rigorous and consistently applied. Actionability is held at 0.93 — no changes in I5 to actionability content.

**Final composite: 0.933 | REVISE**

---

## Detailed Dimension Analysis

### Completeness (0.92/1.00)

**Rubric applied:** 0.9+ = All requirements addressed with depth.

**Evidence (what is present):**

The A-23 upgrade is present and complete at all active content locations in the document. Specifically:
- Document header (line 3): "A-23 confirmed T1-verified per ACL Anthology 2025.findings-emnlp.761"
- Navigation table D2 row: "D2 partially upgraded to MEDIUM (negation accuracy) / LOW (60% claim) in I5"
- Navigation table Synthesis row: "D2 partially upgraded in I5 (A-23 T1 confirmed; negation accuracy = MEDIUM; 60% claim = LOW/UNTESTED)"
- L0 executive summary: Full A-23 confirmation with URL, scope constraint, and note that hallucination rate claim is unaffected
- Confidence Scale Definition table D2 row: Split "MEDIUM for negation accuracy / LOW for 60% claim" with I5 label
- Backup analytical frame: T1 label for A-23 with scope constraint
- Hierarchy table rank 5 footnote: Full URL, scope note, prior limitation resolved
- D2 evidence assembly table: T1 label with URL and scope note
- D2 hierarchy mapping: Full scope discussion distinguishing negation comprehension from hallucination rate
- D2 verdict section: "I5 CHANGE" label, MEDIUM scoped to negation accuracy, 60% remains LOW/UNTESTED
- Evidence Matrix A-23 row: **T1-VERIFIED** with full citation and scope note
- T-001 finding: T1 confirmed with URL, scope: negation comprehension not hallucination rate
- T-003 finding: "structured techniques win (A-23, A-15)"
- Dimension-by-Dimension Summary: D2 shows MEDIUM for negation accuracy with scope constraint
- Confidence Bounds table: Two separate rows distinguishing negation accuracy (MEDIUM) and hallucination rate reduction (LOW)
- IN-003-I1 entry: I5 note on Explanation 2 severity partial reduction
- I4→I5 revision log: Three entries (A23-V-001-I5, D2-C-001-I5, PS-U-001-I5) with full scope constraints
- PS Integration: Updated confidence 0.68 with derivation and scope constraints
- Footer: I5 change note present

No omissions found. The upgrade is executed at every location that previously carried the T1-unverified label.

**Remaining gap (inherent, unchanged from I4):**

CV-002-I2 persists: I-28 and I-32 (context compaction bug reports) remain without direct primary URLs. The synthesis.md Evidence Catalog section reference provides an indirect navigation path. The document correctly discloses this at both locations (Evidence Matrix and T-004 Finding text). This is an inherent evidence access limitation, not a document quality gap.

**Score justification:** The document's completeness is unchanged from I4 in the limiting dimension (CV-002-I2 indirect path). The A-23 upgrade itself was already fully disclosed in I4 (as T1-unverified); converting that disclosure to "T1-verified" improves evidence quality and consistency but does not extend completeness coverage into new territory. Score of 0.92 is carried forward from I4 — the limiting gap is unchanged.

**Improvement Path:**
- The remaining completeness gap is the CV-002-I2 indirect path. If I-28 and I-32 can be identified with specific GitHub issue numbers, completeness would improve. This requires evidence catalog access, not document revision.

---

### Internal Consistency (0.95/1.00)

**Rubric applied:** 0.9+ = No contradictions, all claims aligned.

**Evidence (what is present):**

The split-confidence handling for D2 in I5 is the core consistency test. The MEDIUM confidence label must appear precisely and only where A-23's negation accuracy outcome is referenced, and the LOW confidence label must appear for hallucination rate reduction specifically. This has been verified across all active content locations:

1. The Confidence Scale Definition table D2 row correctly labels I5 as "MEDIUM for negation accuracy; LOW for 60% claim."
2. The Dimension-by-Dimension Summary D2 row shows "MEDIUM for negation accuracy (I5 upgrade from LOW)" with the scope constraint in the limitation column.
3. The Confidence Bounds table has two separate rows: negation accuracy = MEDIUM, hallucination rate reduction = LOW.
4. The D2 verdict section states: "MEDIUM for structured negative techniques improving negation reasoning accuracy (I5 upgrade, scoped)" followed immediately by "LOW for hallucination rate reduction specifically."
5. PS Integration key finding 2 correctly states "MEDIUM-confidence directional improvement in negation reasoning accuracy" and explicitly notes "for hallucination rate reduction specifically, evidence remains LOW."
6. The backup analytical frame correctly shows "MEDIUM for negation accuracy (scope: negation reasoning, not hallucination rate directly); LOW for hallucination rate reduction specifically."

No location is found where MEDIUM is applied to the hallucination rate claim. No location is found where A-23's scope is mischaracterized. The I5 scope constraint note in the revision log explicitly guards against overstatement: "The MEDIUM upgrade is the maximum warranted by the evidence — it reflects what A-23 actually demonstrates, not what would be needed to confirm the PROJ-014 60% hallucination reduction hypothesis."

Prior consistency resolutions (SR-003-I2 clarification blockquote, D2 LOW throughout I3/I4) remain intact and are unchanged by I5. No new contradictions introduced.

**Gaps:**

No material consistency gaps remain. The split-confidence handling is the most complex consistency challenge in I5, and it is executed correctly. The 0.05 gap to 1.00 reflects the inherent complexity of a document that contains direction-constrained language alongside comparative analysis claims — even with the reconciling note, a highly skeptical reader could find residual tension between the NEVER-abandon principle and the MEDIUM-confidence upgrade. This is not a new gap; it is the same residual tension noted in I4.

**Score justification:** Internal Consistency is the strongest dimension in I5. The I5 changes introduce the most complex internal consistency requirement (split confidence applied at 12+ locations) and execute it without errors. Score of 0.95 is held — identical to I4. The 0.05 gap to 1.00 reflects structural complexity, not resolvable inconsistencies.

**Improvement Path:**
- No actionable improvements remain for this dimension.

---

### Methodological Rigor (0.93/1.00)

**Rubric applied:** 0.9+ = Rigorous methodology, well-structured.

**Evidence (what is present):**

The I5 methodological changes demonstrate careful adherence to the confidence scale. The MEDIUM threshold requires "exactly 1 T1 or T2 study." A-23 is now confirmed T1-verified. The methodology applies the threshold correctly: the MEDIUM label is applied to the specific outcome A-23 demonstrates (negation reasoning accuracy), not to the broader hallucination rate reduction claim that A-23 does not test. This is methodologically precise.

The construct-scope constraint is applied rigorously: negation comprehension accuracy (correctly interpreting negated statements) is distinguished from hallucination rate (fabrication of false facts) at every location where the upgrade appears. The I5 revision log entry D2-C-001-I5 states explicitly: "IMPORTANT scope constraint applied: A-23 measures negation comprehension accuracy (correctly interpreting negated statements), not hallucination rate (fabrication of false facts) directly." This distinction is methodologically sound.

The I5 scope constraint note further guards against construct conflation: "The A-23 T1 confirmation resolves the access barrier that caused the I3 downgrade, but does NOT retroactively convert A-23 into evidence for hallucination rate reduction." This is a methodologically honest statement that prevents scope creep.

All prior methodological rigor elements from I4 remain intact: alternative frameworks analysis, hierarchy validity disclosure, backup analytical frame, parsimony analysis (with conditional finding), circularity disclosure.

**Gaps:**

The fundamental methodological tension — researcher circularity (Assumption A-002) — remains unchanged and correctly handled. This is an inherent limitation that the document correctly addresses. No new methodology gaps are introduced by I5.

**Score justification:** Methodological rigor is maintained at the 0.93 level. The I5 change is methodologically exemplary: it applies the confidence scale precisely to the construct the evidence actually measures, without inflation. The remaining gap to 1.00 reflects the structural circularity inherent in the research design — unchanged from I4 and correctly disclosed. Score of 0.93.

**Improvement Path:**
- No document-level improvement remains. The circularity gap requires independent replication as the document states.

---

### Evidence Quality (0.93/1.00)

**Rubric applied:** 0.9+ = All claims with credible citations.

**Evidence (what is present):**

A-23 is now confirmed T1-verified at all document locations. The ACL Anthology URL (https://aclanthology.org/2025.findings-emnlp.761) is provided at every substantive reference to A-23 in the active content. The prior T1-unverified status is preserved only in the I3 change description within the revision log (as a historical record) — the active evidence labels are all "T1 (confirmed)" or "T1 (EMNLP 2025 Findings, confirmed)."

The I4 scorer's assessment was: "If A-23 can be confirmed as T1, D2 would recover its hallucination-specific directional support at T1 level, Evidence Quality increases to approximately 0.94." The I5 scorer observes that the upgrade is more carefully scoped than the I4 prediction assumed: D2's MEDIUM confidence applies to negation accuracy, not hallucination rate. A-23 does NOT provide T1 evidence for hallucination-specific support — it provides T1 evidence for negation reasoning accuracy improvement. This is an important distinction that the document handles correctly.

Net effect on Evidence Quality: The primary evidence gap from I4 (A-23 T1-unverified) is resolved. D2 now has confirmed T1 support for its partially-upgraded MEDIUM claim. The evidence quality for the dimension-level characterizations is now accurate and well-supported.

**Gaps:**

1. **I-28/I-32 access limitation (inherent, correctly disclosed, unchanged from I4):** GitHub issue references for context compaction bug reports remain without direct primary URLs. The indirect path through synthesis.md Evidence Catalog section persists. T-004 finding is labeled T4 LOW confidence, which correctly bounds the impact.

2. **60% hallucination reduction claim (inherent, UNTESTED):** This is not an evidence quality gap per se — it is a correctly-labeled untested claim. No T1 evidence exists, and the document correctly states this. A-23's T1 confirmation does not change the status of the 60% claim.

**Score justification:** Evidence Quality improves from I4's 0.91 to 0.93. The A-23 confirmation resolves the primary evidence constraint and moves D2 from "claims stated without confirmed T1 support" to "claims stated with confirmed T1 support for the specific outcome measured." The I-28/I-32 access limitation remains, preventing 0.95+. Score of 0.93 reflects "all claims with credible citations" across all major claims, with one indirect-path T4 source at LOW confidence.

**Improvement Path:**
- The remaining Evidence Quality ceiling is the I-28/I-32 URL unavailability. If specific GitHub issue numbers can be added to both citation locations, Evidence Quality would improve to approximately 0.95. This requires evidence catalog access, not document revision.

---

### Actionability (0.93/1.00)

**Rubric applied:** 0.9+ = Clear, specific, implementable actions.

**Evidence (what is present):**

No changes to actionability content in I5. PG-001 through PG-005 remain unconditional, evidence-cited, and implementable. PG-003 continues to include the I4 improvement (null-result vocabulary default: positive framing alignment with vendor recommendation unless policy-document conventions prescribe prohibitive vocabulary). The Phase 2 Inconclusive Scenario provides five-point guidance. Recommendations R-001 through R-006 specify four priority Phase 2 pilot conditions with specific condition codes, target models, and exclusion criteria.

The A-23 T1 confirmation does not change the actionability of the guidance — PG-001 through PG-005 were already evidence-based and unconditional. The confirmation provides stronger evidence backing for PG-001 (blunt prohibition underperforms structured alternatives) and PG-002 (specify hierarchy rank), but the guidance itself is unchanged.

**Gaps:**

The PG-003 contingency (organizational policy-document conventions assessment) still requires practitioner judgment for edge cases. This is unchanged from I4 — an inherent limitation of advising under evidence uncertainty.

**Score justification:** Actionability is unchanged from I4. Score of 0.93 carried forward.

**Improvement Path:**
- No actionable document improvements remain. The remaining ambiguity in PG-003 is inherent to advising under evidence uncertainty, as noted in I4.

---

### Traceability (0.94/1.00)

**Rubric applied:** 0.9+ = Full traceability chain.

**Evidence (what is present):**

The A-23 ACL Anthology URL (https://aclanthology.org/2025.findings-emnlp.761) is added at all active content references to A-23. This is a genuine traceability improvement from I4: A-23 was previously labeled "T1-unverified" (no DOI or preprint ID available); it now has a specific, verifiable primary source URL. A reader can directly navigate to the published paper. This is the highest-quality traceability addition possible: a primary source URL, not an indirect path.

Specific locations where the URL appears:
- Hierarchy table rank 5 footnote (full citation + URL)
- D2 evidence assembly table (confirmed; URL provided)
- D2 verdict section (URL in the I5 CHANGE statement)
- L0 executive summary (URL provided)
- T-001 finding (URL confirmed)
- Confidence Bounds table row for negation accuracy (URL referenced)
- PS Integration key finding 2 (URL provided)
- Revision log A23-V-001-I5 entry (full citation with URL)

PS Integration confidence is updated from 0.64 to 0.68 with the explicit derivation (0.7+0.7+0.5+0.5+1.0)/5 = 3.4/5 = 0.68 — mechanically reproducible from the stated dimension-level values.

The I4→I5 revision log accurately records all three changes with sufficient detail for a reader to verify what changed.

**Gaps:**

1. **CV-002-I2 indirect path (inherent, unchanged):** I-28 and I-32 remain without direct primary GitHub issue URLs. The synthesis.md Evidence Catalog section provides the best available indirect path, unchanged from I4. This limits the Traceability ceiling.

**Score justification:** Traceability improves from I4's 0.93 to 0.94. The A-23 URL addition is a direct and specific primary source — a meaningful traceability improvement that earns the 0.01 increment. The I-28/I-32 indirect path limits this from 0.95+. Score of 0.94 reflects full traceability for all document-controllable items with one inherent indirect-path limitation.

**Improvement Path:**
- The remaining traceability gap (I-28/I-32 GitHub issue numbers) requires evidence catalog access, not document revision.

---

## I4 Constraint Resolution Verification

### A-23 T1 Confirmation: Consistency Audit

| Document Location | Prior Status (I4) | I5 Status | Consistent |
|------------------|-------------------|-----------|------------|
| Document header (line 3) | Not present | "A-23 confirmed T1-verified per ACL Anthology 2025.findings-emnlp.761" | CONFIRMED |
| Navigation table D2 row | "D2 LOW throughout (I3 downgrade)" | "D2 partially upgraded to MEDIUM (negation accuracy) / LOW (60% claim) in I5" | CONFIRMED |
| Navigation table Synthesis row | "D2 partially upgraded in I5 (A-23 T1 confirmed...)" | Same with detail | CONFIRMED |
| L0 executive summary | Absent (A-23 constraint was external) | Full A-23 confirmation with URL and scope constraint | CONFIRMED |
| Confidence Scale Definition D2 row | "LOW throughout (I3 downgrade)" | "MEDIUM for negation accuracy; LOW for 60% claim" with I5 label | CONFIRMED |
| Backup analytical frame | "T1: A-23 (negation accuracy, T1-unverified)" | "T1: A-23 (negation accuracy, confirmed EMNLP 2025 Findings); MEDIUM for negation accuracy (scope note)" | CONFIRMED |
| Hierarchy table rank 5 footnote | "T1-unverified" with prior limitation note | T1-VERIFIED label, full URL, scope note, prior limitation resolved | CONFIRMED |
| D2 evidence assembly table | "T1-unverified" label | "T1 (EMNLP 2025 Findings, confirmed; URL)" | CONFIRMED |
| D2 verdict section | "I3 CHANGE: downgraded to LOW" | "I5 CHANGE: A-23 confirmed T1" with MEDIUM scoped to negation accuracy | CONFIRMED |
| Evidence Matrix A-23 row | T1-unverified; no URL | "T1-VERIFIED (I5)"; full citation; URL | CONFIRMED |
| T-001 finding | A-23 referenced without URL | T1 confirmed with URL; scope note | CONFIRMED |
| Dimension-by-Dimension Summary | "LOW throughout" | "MEDIUM for negation accuracy (I5 upgrade from LOW)" with scope in limitation | CONFIRMED |
| Confidence Bounds table | Single row at LOW | Two rows: negation accuracy (MEDIUM), hallucination rate (LOW) | CONFIRMED |
| IN-003-I1 Explanation 2 severity note | No I5 reference | "I5 update: A-23's T1 confirmation partially reduces Explanation 2's severity" | CONFIRMED |
| I4→I5 revision log | Not present (I4 was the last log) | Three entries: A23-V-001-I5, D2-C-001-I5, PS-U-001-I5 with full scope constraints | CONFIRMED |
| PS Integration confidence | 0.64 | 0.68 with derivation (0.7+0.7+0.5+0.5+1.0)/5 = 3.4/5 = 0.68 | CONFIRMED |
| PS Integration key finding 2 | "LOW throughout; 60% claim UNTESTED" | "MEDIUM-confidence directional improvement in negation reasoning accuracy...scope: negation comprehension accuracy, NOT hallucination rate" | CONFIRMED |
| Footer I5 change note | Not present | "A-23 confirmed T1-verified; D2 partially upgraded to MEDIUM for negation accuracy sub-claim; confidence updated to 0.68" | CONFIRMED |

**No active content location retains "T1-unverified" as the current status for A-23. The historical I3 change description in the revision log correctly preserves the downgrade rationale while noting "A-23 has subsequently been confirmed as T1-verified in I5."**

### Split Confidence Consistency Audit

The MEDIUM confidence label must appear for negation accuracy sub-claim and LOW must appear for hallucination rate sub-claim. A verification that no location conflates the two:

- D2 verdict section: MEDIUM for negation accuracy; LOW for hallucination rate specifically; UNTESTED for 60% claim — CONSISTENT
- Confidence Scale Definition table: Split correctly — CONSISTENT
- Dimension-by-Dimension Summary: MEDIUM for negation accuracy with scope in limitation column — CONSISTENT
- Confidence Bounds table: Two rows, distinct claims, distinct confidence levels — CONSISTENT
- PS Integration: D2=MEDIUM=0.7 labeled with scope constraint "negation accuracy confirmed T1; scope limited to negation comprehension not hallucination rate" — CONSISTENT
- Backup analytical frame: Three confidence levels (MEDIUM compliance, MEDIUM negation accuracy, LOW hallucination rate) each labeled separately — CONSISTENT
- I5 scope constraint note: "The MEDIUM upgrade is the maximum warranted by the evidence" — CONSISTENT

**No location found where MEDIUM confidence is applied to the hallucination rate claim. Split confidence is consistently executed throughout.**

---

## Remaining Findings

### Document-Quality Findings

**None.** All findings from I1 through I4 are resolved. No new findings were identified in I5.

### External Evidence Constraints (not document-quality findings)

| Constraint | Nature | Downstream Impact | Change from I4 |
|-----------|--------|-------------------|----------------|
| I-28/I-32 (context compaction bug reports) no direct URLs | GitHub issue references not recoverable from evidence catalog; synthesis.md Evidence Catalog section provides the best available indirect path | Finding T-004 remains T4 LOW confidence; traceability chain terminates at synthesis.md section heading; Completeness capped at 0.92; Evidence Quality capped at 0.93; Traceability capped at 0.94 | UNCHANGED from I4 |

**Note:** A-23 T1-unverified is no longer an external constraint. The I4 primary blocker is resolved.

**The I-28/I-32 URL unavailability is now the sole remaining external evidence constraint. The document handles it correctly with full disclosure.**

---

## Weighted Composite Calculation

| Dimension | Weight | Score | Weighted |
|-----------|--------|-------|----------|
| Completeness | 0.20 | 0.92 | 0.184 |
| Internal Consistency | 0.20 | 0.95 | 0.190 |
| Methodological Rigor | 0.20 | 0.93 | 0.186 |
| Evidence Quality | 0.15 | 0.93 | 0.1395 |
| Actionability | 0.15 | 0.93 | 0.1395 |
| Traceability | 0.10 | 0.94 | 0.094 |
| **TOTAL** | **1.00** | | **0.933** |

**Calibration note:** Initial per-dimension raw scores before downward resolution were Completeness=0.93, Evidence Quality=0.94, Traceability=0.94, yielding a raw composite of 0.938. Leniency bias counteraction resolved adjacent-band uncertainties downward:

- Completeness resolved from 0.93 to 0.92: the A-23 upgrade is complete and correct, but the completeness improvement is marginal — I4 already fully disclosed the T1-unverified status, and that disclosure is now converted to T1-verified. The document coverage was already complete; the evidence characterization is now more accurate. The CV-002-I2 indirect path remains unchanged and is the binding completeness constraint.
- Evidence Quality resolved from 0.94 to 0.93: the I4 scorer's prediction was "approximately 0.93-0.94." The lower bound is taken per leniency counteraction. The I-28/I-32 URL access constraint persists. The A-23 upgrade is correctly scoped (negation accuracy, not hallucination rate) — this is an appropriate partial improvement, not full recovery to 0.95.
- Traceability held at 0.94: the A-23 URL addition is a direct primary source (not indirect) and this is specific, documentable evidence. The difference between 0.93 (I4) and 0.94 (I5) is justified by the addition of a verifiable DOI-equivalent URL at all active content locations. The I-28/I-32 indirect path limits this from 0.95.

Internal Consistency is held at 0.95 — the split-confidence handling is verified consistent at all active content locations. Methodological Rigor is held at 0.93 — construct-scope constraint applied rigorously; structural circularity unchanged. Actionability is held at 0.93 — no I5 changes to actionability content.

**Final score: 0.933 | REVISE**

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension(s) | Current | Target | Recommendation |
|----------|-------------|---------|--------|----------------|
| 1 | Evidence Quality (0.93), Traceability (0.94), Completeness (0.92) | 0.92-0.94 | ~0.95-0.96 | **Identify I-28 and I-32 GitHub issue numbers.** These are the only remaining external evidence constraint. If specific GitHub issue numbers can be added to both the Evidence Matrix entry and the T-004 Finding text (plus the synthesis.md Evidence Catalog reference), the indirect traceability path becomes a direct primary path. This is the single highest-leverage remaining action. Requires access to the Anthropic Claude Code GitHub issue tracker, not document revision. Estimated composite impact: +0.012 to +0.015, potentially reaching 0.945-0.948. |

**Path to PASS at 0.95:** The I5 document is at approximately 0.933, which is the composite after A-23 resolution. The remaining gap to 0.95 is 0.017. This gap is driven by two constraints:

1. **I-28/I-32 URL unavailability** (primary remaining constraint): Currently limits Completeness to 0.92, Evidence Quality to 0.93, Traceability to 0.94. Recovering direct GitHub issue URLs could potentially raise Completeness to 0.93, Evidence Quality to 0.95, Traceability to 0.95+, yielding a composite of approximately 0.945-0.948.

2. **Composite structure**: Even with I-28/I-32 recovery, reaching exactly 0.950 requires near-ceiling scores across most dimensions. The structural circularity limitation (Assumption A-002) will continue to bound Methodological Rigor below 0.95 without independent replication.

**Assessment:** The I5 document is genuinely excellent. It has reached the practical ceiling of what document-level revision can achieve given the inherent evidence access limitations. The gap from 0.933 to 0.95 is primarily an external evidence access gap, not a document quality gap. The document handles all known evidence limitations correctly and transparently.

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing composite — dimension scores were determined individually based on specific document evidence before any composite calculation
- [x] Evidence documented for each score — specific document locations (sections, content descriptions) cited for each dimension
- [x] Uncertain scores resolved downward — Completeness resolved from 0.93 to 0.92 (CV-002-I2 indirect path unchanged; A-23 upgrade does not extend completeness coverage); Evidence Quality resolved from 0.94 to 0.93 (I4 scorer prediction range lower bound; I-28/I-32 constraint persists); Traceability held at 0.94 not inflated to 0.95 (I-28/I-32 indirect path limits ceiling)
- [x] Calibration anchors applied — 0.92 = "all requirements addressed with depth, minor gap"; 0.93 = "strong work"; 0.94-0.95 = "excellent, minor refinements needed"
- [x] First-draft calibration considered — this is a fifth iteration; the score reflects earned improvement through a rigorous revision series
- [x] No dimension scored above 0.95 without justification — only Internal Consistency reaches 0.95; justified by the complete and consistent split-confidence handling at all 12+ active content locations
- [x] Score does not exceed threshold without full justification — composite 0.933 is below the 0.95 threshold; no upward inflation applied
- [x] Score not inflated because document is long or detailed — dimension scores reflect specific rubric criteria
- [x] Disclosed gaps not excused — the I-28/I-32 URL limitations are counted against Evidence Quality, Completeness, and Traceability regardless of correct document handling
- [x] I4 score trajectory respected — I4 = 0.930; I5 = 0.933; improvement of +0.003 reflects the targeted A-23 resolution; score is within the expected post-resolution range
- [x] A-23 upgrade not over-credited — the upgrade is scoped correctly: Evidence Quality improves because D2 now has confirmed T1 support for its MEDIUM claim; Traceability improves because A-23 has a verifiable URL; Completeness does not improve because I4 already had complete disclosures

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.933
threshold: 0.95
weakest_dimension: Completeness
weakest_score: 0.92
critical_findings_count: 0
major_findings_count: 0
minor_findings_count: 0
external_constraints_count: 1
  # I-28/I-32 no direct GitHub URLs (indirect path through synthesis.md Evidence Catalog)
  # Note: A-23 T1-unverified constraint from I4 is RESOLVED — no longer a constraint
iteration: 5
gap_to_threshold: 0.017
score_trajectory:
  I1: 0.743
  I2: 0.790
  I3: 0.893
  I4: 0.930
  I5: 0.933
i4_external_constraint_resolved: true
  # A-23 confirmed T1-verified at all document locations; split confidence consistent
new_findings_i5: 0
document_quality_findings_remaining: 0
improvement_recommendations:
  - "Identify I-28/I-32 GitHub issue numbers — only remaining external evidence constraint; would raise Evidence Quality to ~0.95, Traceability to ~0.95, Completeness to ~0.93; estimated composite impact +0.012 to +0.015"
path_to_pass: "I5 is at 0.933 — a well-executed revision that resolves the I4 primary blocker (A-23 T1 confirmation). The sole remaining external constraint is I-28/I-32 URL unavailability, which limits three dimensions (Completeness, Evidence Quality, Traceability). Identifying direct GitHub issue numbers for I-28 and I-32 could raise the composite to approximately 0.945-0.948. Reaching exactly 0.950 may additionally require the structural circularity limitation (Assumption A-002) to be addressed via independent replication — but 0.945-0.948 may be considered acceptable given the inherent evidence access nature of the remaining constraints."
```

---

*adv-scorer | S-014 LLM-as-Judge | PROJ-014 | 2026-02-28*
*SSOT: `.context/rules/quality-enforcement.md`*
*Prior scores incorporated: I4 report at `phase-2/adversary-comparative-effectiveness-i4.md`*
*Constitutional compliance: P-001 (scores evidence-cited; no inflation), P-002 (report persisted to file), P-022 (gaps documented; score does not exceed threshold; leniency bias counteraction active; A-23 upgrade not over-credited)*
